Chennai, NFAPost: Esperer Onco Nutrition (EON) has announced the appointment of two new senior members for its Research and Development (R&D) team.
Dr Vivek Srivastav and Dr Anubhab Mukherjee have joined the team. Dr Srivastav will serve as the Vice-President of the R&D and Operation. Dr Mukherjee will be serving as the Principal Scientist of the Research and Development division.
EON is destined to understand, treat and help prevent a range of medical conditions by leveraging nutrition and life sciences. The company aims to address specific health conditions with special emphasis on Onco Nutrition and intend to provide a 360 degree solution to global cancer portfolio right from Preventive Oncology to Cancer Disease Management using Nutraceutical as complementary therapy to stage and region specific cancer patients.
“We at Esperer are glad to welcome resourceful intelligentsia in our crucial research and development department. Dr Srivastav and Dr Mukherjee will foster and hone the best research practices and help Esperer Onco Nutrition to develop better mediums to offer nutrition at all stages of the critical disease management focussed on cancer,” said Esperer Onco Nutrition Founder and CEO Raktim Chattopadhyay.
Prior to joining EON, Dr Srivastav was the Director-Research & Development (Enteral Nutrition), North-East South-East Asia (NESEA), Member of Leadership Team at Fresenius Kabi India.
Dr Srivastav said, “I am excited to explore this new opportunity with EON. The vision of whole group and management focus on building science based formulations attracted me the most towards EON.”
Dr Anubhab Mukherjee joins as a Principal Scientist, R&D in Esperer Onco Nutrition (EON) and heads the Hyderabad R&D centre for the organisation as well. He has a Ph.D. from CSIR-Indian Institute of Chemical Technology, India. He has in-depth experience in the cancer and Nanomedicine space and has been a part of two post-doctoral research in the United States of America (USA).
At EON, he plans to spearhead the quest for ultimate nutritional care through different delivery mechanisms for cancer patients. A super specialised researcher, academician and scientist Dr Mukherjee said, “I am motivated to work with Esperer Onco Nutrition and lead a team of bright scientists whose inputs can help me steer my existing knowledge for the larger good of humanity.”